Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Neurosciences/Neurology. Motor neuron diseases

  • You have access
    Diagnostic performance of the visual reading of 123I-ioflupane DaT SPECT images when assessed with or without quantification in patients with movement disorders or dementia
    Jan Booij, Daniel Pryma, Jacob Dubroff, Jian Yu, Rajan Agarwal, Paras Lakhani and Phillip Kuo
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 74;
  • You have access
    Subregional patterns of preferential striatal DAT loss differ in PD, MSA and PSP
    Chengfeng Jiang, Ping Wu, Jianjun Wu, Jingjie Ge, Fangyang Jiao and Chuantao Zuo
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 75;
  • You have access
    Longitudinal Decline of Striatal Subregional F-18 FP-CIT Uptake in Parkinson’s Disease
    Changhwan Sung, JaeSeung Kim, Minyoung Oh, Seung Jun Oh, Sang Ju Lee and Jungsu Oh
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 69;
  • You have access
    Multimodal database of dopaminergic neurotransmission functions in substantia nigra measured by MRI and PET
    Hiroshi Ito, Hiroshi Kawaguchi, Yoko Ikoma, Hitoshi Shimada, Yasuyuki Kimura, Chie Seki, Hiroyuki Takuwa and Tetsuya Suhara
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 72;
  • You have access
    The Parkinson disease related cortical and striatal cognitive pattern in early and delayed F-18 FP-CIT image: evidence for neural correlates between caudate and frontal lobe
    Hye Joo Son, Young Jin Jeong, Hyun Jin Yoon and Do-Young Kang
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 71;
  • You have access
    Regional striatal differences in the rate of dopamine transporter loss in the Parkinson Progression Marker Initiative (PPMI):Relevance to clinical trial design
    John Seibyl, Danna Jennings and Kenneth Marek
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 70;
  • You have access
    Application of texture analysis to DaTscan images for enhanced assessment of progression in Parkinson’s disease
    Arman Rahmim, Yousef Salimpour, Saurabh Jain, Stephan Blinder, Ivan Klyuzhin, Gwenn Smith, Zoltan Mari and Vesna Sossi
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 73;
SNMMI

© 2025 SNMMI

Powered by HighWire